Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-25-004013
Filing Date
2025-01-28
Accepted
2025-01-28 17:08:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 57610
2 form424b3_001.jpg GRAPHIC 3590
3 ex99-1_001.jpg GRAPHIC 2111
  Complete submission text file 0001493152-25-004013.txt   66852
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280414 | Film No.: 25565480
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)